doravirine 100 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Delstrigo]

RxCUI: 2055815
RxNorm name: doravirine 100 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Delstrigo]
Display name: doravirine 100 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Delstrigo]
Full name: doravirine 100 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Delstrigo]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:21

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
DELSTRIGO	DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE	Merck Sharp & Dohme LLC	cd1e9f84-607a-46d3-b01e-2736018d67b6	2026-07-08	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2055815

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
cd1e9f84-607a-46d3-b01e-2736018d67b6	doravirine 100 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Delstrigo]	SBD	23	These highlights do not include all the information needed to use DELSTRIGO safely and effectively. See full prescribing information for DELSTRIGO. DELSTRIGO ® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018	20251029
cd1e9f84-607a-46d3-b01e-2736018d67b6	DORAVIRINE 100 MG / 3TC 300 MG / Tenofovir disoproxil fumarate 300 MG Oral Tablet [Delstrigo]	SY	23	These highlights do not include all the information needed to use DELSTRIGO safely and effectively. See full prescribing information for DELSTRIGO. DELSTRIGO ® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018	20251029
cd1e9f84-607a-46d3-b01e-2736018d67b6	Delstrigo (doravirine 100 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG)) Oral Tablet	SY	23	These highlights do not include all the information needed to use DELSTRIGO safely and effectively. See full prescribing information for DELSTRIGO. DELSTRIGO ® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018	20251029
cd1e9f84-607a-46d3-b01e-2736018d67b6	Delstrigo 100 MG / 300 MG / 300 MG Oral Tablet	PSN	23	These highlights do not include all the information needed to use DELSTRIGO safely and effectively. See full prescribing information for DELSTRIGO. DELSTRIGO ® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018	20251029